Abeona Therapeutics Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.10 |
25.12 |
106.05 |
194.43 |
305.04 |
382.06 |
| Przychód Δ r/r |
0.00% |
25016.67% |
322.24% |
83.34% |
56.89% |
25.25% |
| Przychód (min) |
0.05 |
20.40 |
64.75 |
99.95 |
156.82 |
196.41 |
| Przychód (max) |
0.20 |
34.14 |
130.36 |
383.82 |
602.16 |
754.20 |
| EBITDA (średnia) |
-0.06 |
-15.07 |
-63.63 |
-116.66 |
-183.02 |
-229.23 |
| EBIT (średnia) |
-0.06 |
-15.07 |
-63.63 |
-116.66 |
-183.02 |
-229.23 |
| EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-70.53 |
-21.62 |
8.72 |
66.78 |
101.18 |
125.20 |
| Zysk netto % |
-70531.14% |
-86.07% |
8.22% |
34.35% |
33.17% |
32.77% |
| EPS (średnia) |
-1.72 |
-0.53 |
0.14 |
1.09 |
2.46 |
3.05 |
| Liczba analityków (Przychody) |
4 |
5 |
7 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
3 |
4 |
5 |
4 |
3 |
2 |
| symbol |
ABEO |
ABEO |
ABEO |
ABEO |
ABEO |
ABEO |